Morderna (NASDAQ: MRNA) and IBM (NYSE: IBM) reported plans to explore technologies, blockchain, hybrid cloud and artificial intelligence that may help support smarter COVID-19 management. The plan is to identify ways that technology can be used to accelerate information sharing between healthcare providers, governments, life science organizations and individuals to improve confidence in vaccine programs and increase rates of vaccination, and in result, reducing community spread.
U.S. integration will initially focus on vaccine management solutions and Digital Health Pass, which utilizes blockchain technology to help individuals maintain control of their personal health information and share it in a secure, verified and trusted way.
“Moderna is committed to working with a coalition of partners to increase education and awareness of the importance of vaccination to help defeat COVID-19,” said Michael Mullette, VP, Managing Director North America Commercial Operations of Moderna. “We look forward to working with IBM to apply digital innovations to build connections between organizations, governments, and individuals to instill confidence in COVID-19 vaccines.”
“If ever there was a time to rally around open technology and collaboration, it’s now,” said Jason Kelley, Managing Partner, Global Strategic Alliances Leader for IBM. “As governments, pharmacy chains, healthcare providers and life sciences companies continue to scale and connect their tools, and as new players enter the supply chain, open technology can help drive more transparency and bolster trust, while helping to ensure accessibility and equity in the process.”